Close Menu

NEW YORK — Women's health diagnostic firm Progenity on Thursday announced a 70 percent drop in second quarter revenues, its first financial results since going public earlier this year.

For the three-month period ended June 30, Progenity reported $17.3 million in revenue, down from $57.2 million in the year-ago quarter. Second quarter revenues were impacted by "a $10.3 million accrual for refunds to government payors," the firm said in a statement.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Nebula Genomics will be auctioning George Church's genome as a nonfungible token, according to The Scientist.

Anthony Gregg, the outgoing president of the American College of Medical Genetics and Genomics, has resigned after using racially insensitive language. 

Facebook has developed an artificial intelligence approach to predict how drugs interact in cells, New Scientist reports.

In PNAS this week: adaptations among high-altitude Mycobacterium tuberculosis, response of multiple myeloma cells to chemotherapy-induced stress, and more.